Abstract
Long-acting bronchodilators are the mainstay of pharmacological treatment for patients with chronic obstructive pulmonary disease (COPD). The aim of this review is to provide an overview of the clinical studies evaluating the safety and efficacy of inhaled aclidinium bromide, a novel long-acting anticholinergic bronchodilator, for the treatment of COPD.
| Original language | English |
|---|---|
| Journal | The Open Respiratory Medicine Journal |
| Volume | 6 |
| Pages (from-to) | 150-4 |
| Number of pages | 5 |
| ISSN | 1874-3064 |
| DOIs | |
| Publication status | Published - 2012 |
Fingerprint
Dive into the research topics of 'Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS